Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone

Go back to Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone
ARROWHEAD RESEARCH (NASDAQ: ARWR) Delayed: 76.40 --0 (-0%)
Previous Close $76.40    52 Week High $8.22 
Open $76.40    52 Week Low $3.07 
Day High $76.40    P/E N/A 
Day Low $76.40    EPS $-1.30 
Volume 660       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 18.95 --0 (-0%)
Previous Close $18.95    52 Week High $63.73 
Open $18.95    52 Week Low $8.00 
Day High $18.95    P/E N/A 
Day Low $18.95    EPS $-5.69 
Volume 231